| In ZINC since | Heavy atoms | Benign functionality |
|---|---|---|
| November 16th, 2005 | 28 | Yes |
(5Z,7E)-(3R)-9,10-seco-5,7,10(19)-cholestatrien-3-ol
3-epivitamin D3 / 3-epicholecalciferol
| Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
|---|---|---|---|---|---|---|---|---|---|---|
| Ref Reference (pH 7) | 7.68 | 13.53 | -2.13 | 1 | 1 | 0 | 20 | 384.648 | 6 | ↓ |
| Note Type | Comments | Provided By |
|---|---|---|
| PUBCHEM_PATENT_ID | US5698714 | IBM Patent Data |
| Target | Vascular cell adhesion protein 1(P19320)&E-selectin(P16581)&Collagen alpha-2(I) chain(P08123)&Prolactin(P01236)&Ornithine decarboxylase(P11926)&Activity-regulated cytoskeleton-associated protein(Q7LC44)&Tyrosine 3-monooxygenase(P07101)&BDNF/NT-3 growth fa | Herbal Ingredients Targets |
